Introduction {#S1}
============

Mitochondria, largely known as the powerhouse of the cell, play a pivotal role in modulating cellular physiology ([@B102]). Mitochondria contain their own genome, including 13 polypeptide encoding genes, a small and a large rRNA gene and 22 tRNA genes ([@B65]; [@B1]; [@B182]). The mtDNA-encoded polypeptides form a core subunit of the energy generating enzyme complexes that mediate oxidative phosphorylation (OXPHOS) ([@B182]). Mitochondria facilitate cellular functions such as ATP production, apoptosis ([@B184]), metabolism ([@B169]), calcium (Ca^2+^) homeostasis modulation ([@B139]; [@B14]; [@B174]) and reactive oxygen species (ROS) generation ([@B109]). As they play a central role in cellular physiology, it does not come as a surprise that mitochondrial dysfunction is observed in many pathophysiological conditions ([@B181]; [@B117]). Mitochondrial dysfunction associated diseases are widespread and include neurodegenerative ([@B164]; [@B80]) and cardiovascular diseases ([@B176]; [@B86]), diabetes and metabolic syndrome ([@B116]; [@B78]), neurobehavioral and psychiatric diseases ([@B98]; [@B142]), gastrointestinal disorders ([@B27]), muscular atrophy ([@B135]) and cancer ([@B183]). Numerous studies have also shown the involvement of mitochondria in mediating the inflammatory response of immune cells ([@B52]; [@B179]) and chronic infections ([@B58]; [@B7]).

Inflammation is defined as the response generated by the immune cells upon any kind of infection or tissue injury and is a part of many physiological and pathophysiological processes ([@B103]). A regulated inflammatory response is generally considered beneficial as it is involved in healing and the tissue repair process, as well as the prevention of further tissue or cell injury. However, this response can become detrimental if it occurs in an uncontrolled manner ([@B103]). Several severe diseases are linked with chronic uncontrollable inflammation states ([@B74]), including autoimmune disorders such as multiple sclerosis ([@B60]) and type 1 diabetes ([@B95]). In 2005, it was demonstrated that the mitochondrial protein termed as mitochondrial anti-viral signaling (MAVS) associates with viral RNA in cases of viral infection ([@B151]). This interaction activates the nuclear factor (NF)-κB signaling pathway and eventually elicits the inflammatory response by production of type I interferons (IFN-1), such as interferon-β ([@B151]; [@B145]). In addition, it was indicated that mitochondria are a missing link in explaining the similar inflammatory responses found in two different phenomena, sepsis and systemic inflammatory response syndrome (SIRS) ([@B194]). Zhang's group showed that mitochondrial derived damage associated molecular patterns (DAMPs) have n-formylated peptides similar to that of bacteria and are involved in attracting neutrophils, a component of the innate immune system. These peptides were shown to activate neutrophils by binding to their surface protein -- formyl peptide receptor-1 (FPR1) -- to mediate the upregulation of mitogen activated protein kinase (MAPK) signaling pathways leading to chemotaxis. Thus, it was concluded that the immune response to injury/trauma mimics sepsis by mitochondrial DAMPs that activate pattern recognition receptors (PRRs) and FPR1, which are normally activated by bacterial pathogen-associated molecular patterns (PAMPs). This similarity of the inflammatory response generated by mitochondrial and bacterial peptides can be explained by the 'endosymbiotic theory' of mitochondrial origin ([@B144]; [@B64]). This initial evidence indicated the potential role of mitochondria in infection by inducing an inflammatory response by immune cells.

In addition to their response to injury or infection, inflammatory processes also facilitate 'inflammaging' ([@B146]), a process where accelerated aging is mediated via changes in the redox-state of the cell. The role of mitochondria in inflammaging has been extensively discussed in a recent review ([@B162]) and hence, will not be focused on here. In this review, we will describe and discuss the various mechanisms by which mitochondria determine the generation of inflammatory responses (section "Mitochondria and Inflammatory Response"). In addition, it is well established that mitochondrial ion channels contribute to many physiological and pathophysiological processes *via* modulating the mitochondrial function ([@B123], [@B122]; [@B121]; [@B165]; [@B133]; [@B81]; [@B9]). Therefore, in section "Mitochondrial Ion Channels and Inflammatory Response," we discuss some of the mitochondrial ion channels and their significance in inflammatory responses.

Mitochondria and Inflammatory Response {#S2}
======================================

Over the years, mitochondria have emerged as playing a vital role in evoking immune responses. Mitochondrial metabolic pathways, antioxidant systems, Ca^2+^ homeostasis, mitochondrial DNA and ROS are key determinants of immune response ([@B3]). Therefore, this section discussion is primarily focused on how mitochondrial dysfunction both at the genomic and functional level impact an inflammatory response.

Mitochondrial Ca^2+^ and Inflammatory Response {#S2.SS1}
----------------------------------------------

Mitochondria are known to be involved in Ca^2+^ handling ([@B127]). They are in close proximity to the endoplasmic reticulum (ER) and plasma membrane, which probably makes them respond to changes in cytosolic Ca^2+^ ([@B57]). It is established that increased mitochondrial Ca^2+^ is a primary modulator for the production of cardiomyocyte tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-6, leading to cardiac inflammation or dysfunction upon injury or infection ([@B94]). Interestingly, it was demonstrated that the mitochondrial Ca^2+^ exchange inhibitor, ruthenium red, decreased ROS levels, leading to reductions in pro-inflammatory mediators ([@B94]; [@B92]). Thus, suggesting that ROS modulation could be one of the mechanisms by which mitochondrial Ca^2+^ can influence inflammatory pathways. Mitochondrial Ca^2+^ accumulation as a result of cytosolic Ca^2+^ changes is known to elevate ROS generation *via* multiple mechanisms. These include (1) activation of the tricarboxylic acid cycle (TCA), which is a driving force for the electron transport chain (ETC); and (2) stimulation of nitric oxide (NO) synthase that increases NO levels ([@B93]; [@B31]). It was demonstrated that both exogenous addition ([@B22]; [@B30]) and an increase in the endogenous levels of NO can bind and inhibit the ETC complexs I-IV thereby leading to increased ROS production ([@B31]). Increased mitochondrial Ca^2+^ can bind to the oxidized state of cardiolipin ([@B66]; [@B21]) and trigger the release of intermembrane space proteins, notably cytochrome c, into cytosol which then activates caspase proteases to trigger apoptosis ([@B184]). This results in opening of the mitochondrial permeability transition pore (mPTP), causing a loss of mitochondrial membrane potential (Ψ~*mito*~) and triggering cell death ([@B15]; [@B20]; [@B63]; [@B16]). Furthermore, cell death due to increased Ca^2+^ in mitochondria can also serve as a mechanism for triggering inflammatory responses independent of ROS ([Figure 1](#F1){ref-type="fig"}).

![Schematic representation of the mitochondrial dysfunction leading to inflammation. Defects in mitochondrial function such as increased ROS generation, increased calcium overload, increased apoptosis and decreased mitophagy is known to activate inflammatory pathways and to manifest in several inflammatory disorders ([@B92]). Modulation of mitochondrial ion channel expression including (1) a decrease in UCP2 ([@B6]; [@B177]; [@B50]; [@B12]) (2) an increase in VDAC2 ([@B196]), (3) an increase in expression of CLICs ([@B46]; [@B166]), and (4) an increase in expression of MCU ([@B138]; [@B4]; [@B26]) have been reported to induce excessive ROS production, NLRP3 inflammasome activation and calcium overload, respectively, thereby triggering pro-inflammatory signals. Thus, targeting these channels could be a potential therapeutic strategy for treating inflammatory disorders.](fphys-11-00258-g001){#F1}

Mitochondria and Inflammasome Complex {#S2.SS2}
-------------------------------------

Mitochondria can regulate the formation of inflammasomes ([@B111]; [@B168]; [@B196]; [@B92]). An inflammasome is a multi-protein complex which upon activation results in the stimulation of caspase-1 that in turn upregulates several inflammatory cytokines, including IL-1β and IL-18, leading to the stimulation of an inflammatory response ([@B163]). Mitochondrial DAMPs are known to activate cytoplasmic nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs). One of the well-studied NLRs showing a high association with inflammatory diseases is NLRP3. It is one of the 22 human NLR family members. Once activated, NLRP3 causes the oligomerization and recruitment of the apoptosis-associated spec-like protein containing a caspase recruitment domain (ASC) and pro-caspase 1, forming a multiprotein NLRP3 inflammasome complex ([@B168]; [@B92]). This association is considered vital for the activation of pro-caspase 1 and downstream inflammatory events ([@B99]). Mitochondrial ROS are capable of NLRP3 inflammasome activation ([@B39]; [@B23]; [@B196]) through the inhibition of complex I or III of mitochondrial respiratory chain results in ROS generation which subsequently activates the inflammasome complex ([Figure 1](#F1){ref-type="fig"}). Furthermore, inhibition of mitophagy/autophagy leads to spontaneous inflammasome activation due to the presence of damaged mitochondria ([@B196]). In agreement with this, macrophages from mice lacking autophagosomal component LC3B and beclin-1 release more IL-1β and IL-18 in response to lipopolysaccharides (LPS) and ATP ([@B111]). Mitochondrial morphology in these knock out macrophages was altered, for example, mitochondria were swollen and produced a greater amount of ROS ([@B111]). An inability to remove these damaged mitochondria causes the persistence of the inflammatory states. The excessive ROS produced when not effectively resolved by the scavenging mechanism becomes a cause of uncontrolled inflammatory response in certain diseased conditions ([@B92]). Therefore, targeting mitochondrial ROS and the NLRP3 inflammasome complex has high potential as a therapeutic agent in many types of inflammatory disease. Recently, it was demonstrated that inhibiting the enzyme choline kinase (ChoK), which is required for phosphatidylcholine synthesis, inhibits NLRP3 inflammasome activation *via* enhancing the mitophagy of damaged mitochondria ([@B148]). Choline was targeted as its uptake was high within inflammatory sites, and reduction of choline uptake altered the mitochondrial lipid profile, decreased ATP synthesis and activated AMP-activated protein kinase (AMPK) ([@B148]). Activation of AMPK recruits dynamin related peptide (DRP1) to mitochondria, triggering mitophagy ([@B148]). Interestingly, ChoK inhibitor treatment reversed Muckle-Well syndrome, which is caused by mutation in NLRP3 genes ([@B148]). As opposed to other existing drugs that can block only IL-1β, ChoK inhibitors are efficient molecular targets for inflammatory diseases as it can inhibit both IL-1β and IL-18, thus inactivating NLRP3 inflammasome ([@B148]). This study further suggests that removal of damaged mitochondria could be successfully used as a therapeutic strategy to rescue uncontrollable inflammatory disease states.

Mitochondrial DNA Mediated Inflammatory Response {#S2.SS3}
------------------------------------------------

The role of damaged mitochondrial DNA (mtDNA) in the inflammatory response received attention when an increased concentration of mtDNA was detected in the synovial fluid of rheumatoid arthritis (RA) patients ([@B33]). It was further shown that purified human and murine mtDNA was able to induce an inflammatory response mediated by monocytes/macrophages, but not by T or B-cells. Interestingly, neither human nor murine nuclear DNA triggered such an inflammatory response. The mechanism of inflammasome activation was attributed to unmethylated CpG motifs and oxidative damage adducts observed in mtDNA ([@B33]). In non-immune cells such as mouse primary astrocytes, it was reported that upon transfection, oxidant-initiated degraded mitochondrial polypeptides (DeMPs) induced the release of pro-inflammatory cytokines IL-6, monocyte chemotactic protein-1 (MCP-1), and TNF-α ([@B101]). An increased expression of proinflammatory IL-1β was observed implicating the role of DeMPs in inflammasome activation. This study indicated degraded mtDNA was a new subtype of mitochondrial DAMPs possibly involved in neurodegeneration ([@B101]) *via* activating an inflammatory response. Although several studies suggested that damaged mtDNA was necessary for inflammasome activation, the mechanism of how damaged mitochondria mediated these pro-inflammatory effects was not clear. A recent study shed light on this and showed that the binding of newly synthesized mtDNA to NLRP3 inflammasome is necessary for its activation ([@B195]). To elucidate what triggers new mtDNA synthesis, authors found that upon binding to its target receptor TLR4, NLRP3 activators such as LPS initiate the expression of enzyme cytidine monophosphate kinase 2 (CMPK2), a rate-limiting enzyme that supplies dNTPs for mtDNA synthesis. The synthesis of mtDNA after the engagement of TLRs was concluded to be a pre-requisite for initiating NLRP3 signaling, as the macrophage lacking CMPK2 did not exhibit any inflammasome activation ([@B195]). In addition, it was demonstrated that the new mtDNA fragments are oxidized by ROS. Contradictory to earlier reports, this study shows that even oxidized nuclear DNA exhibited these phenomena ([@B195]), suggesting that "oxidized" DNA might be the key signal for this effect. Although this study provided a new concept of how mtDNA affects the inflammasome activation, there are still some unanswered questions, such as: (1) are only the newly synthesized mtDNA prone to oxidation by ROS? and (2) what triggers the ROS production that oxidizes the newly synthesized mtDNA? ([@B110]). Nevertheless, these studies provide fascinating evidence to enhance our understanding of how mitochondria mediate the inflammatory signaling pathway and opens up a plethora of molecular targets for therapy.

mtDNA can also induce inflammatory effects via the NF-κB dependent pathway ([@B179]). Some of these effects include mitochondrial DNA-dependent activation of cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING), leading to an IFN-1 response ([@B187]). mtDNA can bind to cytosolic DNA sensors (cGAS) that upon binding to DNA produces cGAMP. The cGAMP produced would eventually bind to the ER membrane adaptor STING, and would activate it by changing the conformation of STING. This causes translocation of STING to ER-Golgi sites. During this process, it recruits and activates TANK binding kinase 1 (TBK1), which further phosphorylates the transcription factor interferon regulatory factor (IRF3). Phosphorylated IRF3s translocate to the nucleus and cause the activation of an IFN-1 response that triggers both innate and adaptive immunity ([@B140]; [@B187]). Apart from IFN-1, the nuclear translocation of NF-κB was also observed upon mitochondrial outer membrane permeabilization (MOMP) which instigates transcription of pro-inflammatory genes ([@B61]).

Mitochondrial Cell Death Signaling and Inflammatory Response {#S2.SS4}
------------------------------------------------------------

The involvement of mitochondria in the intrinsic pathway of apoptosis indicates that mitochondria are not only the site of interaction of anti- and pro- apoptotic proteins, but also the site of signals that initiate the activation of caspases ([@B184]). Rupturing of the mitochondrial outer membrane by the pro-apoptotic family of proteins BAX and BAK is the initial step in triggering apoptosis. Apoptotic cells along with NF-κB signaling pathways trigger signals for the activation of NLRP3 inflammasome and the subsequent production of IL-1β. Apoptotic cells cause the release of oxidized mtDNA into the cytosol, which ultimately binds to the inflammasome complex and activates it ([@B154]; Figure. 1). In addition to this, even silencing of the anti-apoptotic protein Bcl-2 increases IL-1β secretion, whereas Bcl-2 overexpression reverses it ([@B154]), further showing that damaged mitochondria initiates inflammation via upregulating multiple pathways.

Mitochondrial Ion Channels and Inflammatory Response {#S3}
====================================================

There is extensive literature on the mitochondrial dysfunction associated with the generation of an inflammatory response and its impact on many chronic diseases ([@B92]; [Table 1](#T1){ref-type="table"}). In addition, the continuous production of ATP by mitochondria requires a huge electrochemical driving force to maintain a proton gradient across the mitochondrial membrane ([@B107]; [@B121]). In earlier days, it was postulated that the mitochondrial membrane possesses a low- permeability of ions in order to maintain the electrochemical driving force; thus, ruling out the possibility of ion channels, transporters and exchangers in mitochondrial membranes ([@B121]). Nevertheless, over the years, there have been identification of channels and ionic conductances in mitochondria ([@B121]; [@B165]; [@B84]). Some of these channels and transporters are active under physiological conditions, whereas others get activated due to pathophysiological conditions to determine the fate of the cell ([@B121]). Additionally, they play a key role in maintaining the ionic homeostasis in response to changes in the cytosolic ionic concentration. Mitochondrial ion channels and transporters are key regulators of redox signaling and are involved in the production of ROS and reactive nitrogen species (RNS) ([@B123]; [@B124]). They are also known to regulate other functions of mitochondria such as apoptosis, mitophagy and ATP production. As mitochondrial ion channels modulate multiple functions of mitochondria, they may be important in inducing inflammatory responses via the different mechanisms discussed in section "Introduction." However, there is very little understanding of how these mitochondrial ion channels modulate immune cell activation and what role they play in regulating pro-inflammatory responses. In the subsequent subsections, we will focus on the mitochondrial ion channels and their probable role in modulating pro-inflammatory responses.

###### 

List of Inflammatory Diseases Associated With Mitochondrial Dysfunction.

  Name of the disease                          Mitochondrial defects                                                                                                                                                                          References
  -------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------
  Osteoarthritis and rheumatoid arthritis      Compromised mitochondrial respiration complex activities, ATP synthesis, ψ~*m*~ and increased oxidative stress                                                                                 [@B77]; [@B97]; [@B41]; [@B54]; [@B91]; [@B19]; [@B92]
  Inflammaging                                 Inflammasome activation, decreased mitochondrial respiration, increased glycolysis                                                                                                             [@B56]; [@B162]
  Cardiovascular disorders and heart failure   Increased oxidative stress, increased mitochondrial Ca^2+^, mtDNA mutations                                                                                                                    [@B94]; [@B59]; [@B120]; [@B92]
  Neurological disorders                       Oxidative stress leading to release of pro inflammatory cytokine                                                                                                                               [@B188]; [@B178]; [@B92]
  Metabolic disorders (diabetes and obesity)   Oxidative stress, inflammasome activation                                                                                                                                                      [@B186]; [@B100]; [@B136]; [@B191]; [@B92]
  Sepsis                                       Inhibition of mitochondrial complex activities, inflammasome activation                                                                                                                        [@B5]; [@B193]; [@B92]
  Cancer                                       Defect in mitochondrial function of tumor infiltrating T-cells Loss of PGC1α), Alteration of T-cell function and macrophages polarization due to metabolic changes in tumor microenvironment   [@B55]; [@B32]; [@B149]

Uncoupling Proteins {#S3.SS1}
-------------------

Uncoupling proteins (UCPs) are integral membrane proteins located at the inner mitochondrial membrane. There are five known mammalian homologs of UCP (UCP1--UCP5) ([@B2]; [@B82]; [@B133]; [@B137]). Specifically, UCP1--UCP3 exhibit high sequence homology and are considered to be anion carriers ([@B24]; [@B133]). In order to maintain the electrochemical gradient for the production of ATP, oxidative phosphorylation requires coupling of the transfer of electrons through the ETC to the pumping of protons across the inner mitochondrial membrane ([@B2]; [@B121]; [@B165]). However, oxidative phosphorylation is not completely coupled, which eventually leads to the progression of ETC without ATP production ([@B2]). This results in protons returning back to the matrix, and the energy derived from oxidation of substrates is released as heat ([@B2]). UCP1 is the main regulator of this process in brown adipose tissue (BAT) ([@B114]), as they are predominantly present in BAT. This mechanism is important in regulating non-shivering thermogenesis in newborns, hibernating animals and over fed rodents ([@B118]). In addition, UCP1 expression at both the mRNA and protein levels was also detected in some cells of white adipose tissue (WAT) which further increased upon cold or beta-adrenergic receptor agonist treatment ([@B37]; [@B85]). The UCP1-expressing cells in WAT are termed as "beige" or "brite" adipocytes because of their morphological and functional similarity to brown fat ([@B180]; [@B190]; [@B153]). Interestingly, UCP1-independent thermogenic mechanisms were also demonstrated in beige adipocytes of *UCP1*^--/--^ mice ([@B170]) raising the question of whether all the beige adipocytes of abdominal white fat express UCP1. In a recent report, mitochondrial patch clamping was performed in beige fat of two distinct adipocytes -- inguinal and epididymal -- and their thermogenic H^+^ leak (*I*~*H*~) properties were compared ([@B18]). It was demonstrated that the β3-adrenergic receptor agonist induced UCP1-dependent *I*~*H*~ properties in all the inguinal beige mitochondria, but only ∼15% of newly formed epididymal beige mitochondria exhibited UCP1-dependent proton leaking ([@B18]). This study further confirmed the existence of UCP1-positive and UCP1-negative beige fat cells and UCP1-independent mechanism of thermogenesis ([@B18]). Further, the possibility of additional UCP1-independent thermogenicity mechanisms as well as the function of other UCPs like UCP2 and UCP3 in mediating thermogenesis is still an open area of research.

Anion channel activity was associated with UCPs as they were shown to be involved in mitochondrial swelling ([@B115]). Furthermore, this activity also showed Cl^--^ conductance in reconstituted bilayers ([@B75]; [@B72]). Reconstitution of UCP1 in liposomes revealed chloride channel properties using patch-clamp technology ([@B72]). The conductance was reported to be around 75 pS in symmetrical 100 mM KCl, and the channel closed at high positive potential on the matrix side of UCP. It was also reported that the channel gating switched from slow open-closure transitions to fast flickerings at holding potentials above +60 mV. Their selectivity for different anions was found to be Cl^--^ \> Br^--^ \> F^--^ \> SCN^--^ \> I^--^ \> NO~3--~ \> SO~4^2--^~ \> HPO~4^2^~-- \> gluconate ([@B72]).

The role of the UCP2 homolog in inflammatory responses and immunity was determined in 2000 ([@B6]). The expression of UCP2 was found to be higher in the spleen and isolated macrophages. Upon infection with *Toxoplasma gondii*, *UCP2*^--/--^ mice were found to be resistant to infection in comparison to wild type mice. Parasitic cysts and inflammation sites were also significantly reduced in case of *UCP2*^--/--^ mice. Moreover, macrophages from *UCP2*^--/--^ mice generate more ROS than wild type mice upon *T. gondii* infection ([@B6]). The inhibition of UCP2 resulted in increased ROS generation in macrophages ([Figure 1](#F1){ref-type="fig"}; [@B112]; [@B51]). These results indicate the potential role of UCP2 in regulating ROS generation in macrophages and further regulation of inflammatory responses. In addition, it was observed that UCP2 knocked down macrophages show an increased expression of proinflammatory cytokines ([@B12]). UCP2 knock down was also associated with the pro-inflammatory response in autoimmune encephalomyelitis, a murine model of multiple sclerosis ([@B177]). T-cell proliferation as well as B-cell response was increased in the *UCP2*^--/--^ mice. CD4 T-cells produced higher levels of pro-inflammatory cytokines, such as TNF-α and IL-2. Similar to macrophages, UCP2-deficient CD4 and CD8 T-cells demonstrated increased ROS emission ([@B177]). In an autoimmune disease model of streptozotocin (STZ) induced diabetes, it was observed that knock down of UCP2 aggravated the disease with increased intra-islet infiltration of macrophages ([@B50]). In comparison to wild type macrophages, *UCP2*^--/--^ macrophages showed increased IL-1β and NO secretion leading to a futher increase in NO/ROS mediated damage of β-islet cells ([@B50]). Overall, the inflammation was stronger in *UCP2*^--/--^ mice causing a worsened disease in the mice ([@B50]). Interestingly, pathogens have also evolved to use this strategy to manipulate the expression of UCP2 in order to respond to a host's immune system. It was observed that *Leishmania* infection causes upregulation of UCP2, to suppress host macrophage defense mechanisms, likely to prevent a ROS-mediated inactivation of the host defense ([@B12]). Overall, these results signify the potential involvement of the mitochondrial transporter UCP2 in modulating inflammatory responses *via* regulating mitochondrial ROS in both adaptive and innate immune cells.

Voltage Dependent Anion Channels {#S3.SS2}
--------------------------------

Voltage dependent anion channels (VDAC) was the first mitochondrial ion channel to be reconstituted and studied at a single channel level ([@B150]; [@B36]). It is a well-established outer mitochondrial anion channel protein ([@B150]; [@B34]; [@B113]; [@B133]). There are three isoforms of VDAC in mammals ([@B165]; [@B133]; [@B134]). They are also referred to as porins ([@B192]). Using planar lipid bilayers, the single channel conductance of all porins including the mammalian version was determined to be 4--5 nS, in symmetrical 1 M KCl solution, except that of *Paramecium* ([@B42]; [@B165]). VDAC has a weak anion selectivity but can also conduct Ca^2+^ and has a potential binding site for it ([@B28]). VDAC is associated with cellular apoptosis. It was observed that upon binding to the Bcl2 family of proteins BAX and BAK, the size of the VDAC pore increases, which causes the escape of cytochrome c ([@B155]; [@B10], [@B11]) thereby triggering apoptosis. VDAC1 is over expressed in cancer cells and silencing of it reduces cancer progression ([@B156]). It plays a role in the progression of cancer *via* its association with hexokinase 1 (HK1) and hexokinase 2 (HK2) in aerobic glycolytic cancers ([@B189]). One of the reasons for the diverse role of VDAC1 could be due its localization in the outer mitochondrial membrane which allows it to mediates cellular functions *via* affecting mitochondrial functions.

Voltage dependent anion channel is involved in the activation of the NLRP3 inflammasome complex ([@B196]). It was demonstrated that amongst the inhibition of all the isoforms of mammalian VDAC, VDAC1, and VDAC2 showed a reduced activation of inflammasome complexes in the presence of activators of inflammasomes such as R837, silica, alum and nigericin ([@B196]; [Figure 1](#F1){ref-type="fig"}). A significant reduction of caspase 1, ROS and IL1β secretion was observed in the case of VDAC1 and VDAC2 knockdown ([@B196]). Downregulation of VDAC3 did not show any effect in modulating NLRP3 inflammasome activity. Once activated, NLRP3 inflammasome associates with the mitochondrial associated membrane (MAM) ([@B196]). As VDAC is shown to be essential for metabolite and Ca^2+^ exchange between the MAM and the mitochondria ([@B35]) there is a high possibility that VDAC is one of the potential connecting links between the interactions of inflammasome complexes with MAM and the mitochondria.

Chloride Intracellular Channel Proteins {#S3.SS3}
---------------------------------------

Chloride intracellular ion channel proteins (CLICs) are a unique class of ion channel proteins. They exist in both soluble and integral membrane forms ([@B8]; [@B157]; [@B133]; [@B68]). Unlike other ion channel proteins, they possess a single transmembrane domain ([@B157]; [@B69], [@B68]; [@B133]). They show high structure and sequence similarity to the glutathione S transferase (GST) family of proteins ([@B38]; [@B157]). CLICs are conserved across different species. There are six paralogs of CLICs reported in mammals, identified as CLIC1-CLIC6, four in *Arabidopsis thaliana* (*At*DHAR1-*At*DHAR4), three in invertebrates \[one in *Drosophila Melanogaster* (*Dm*CLIC) and two in *Caenorphabditis elegans* (EXC4 and EXL1)\] ([@B87], [@B88], [@B90]; [@B157]; [@B69], [@B68]; [@B133]). Recently, a homolog of CLIC, stringent starvation protein A (SspA), was identified and characterized for its biophysical properties in prokaryotes ([@B90]; [@B69]). As the name suggests, CLICs localize to various intracellular organelles such as the ER, mitochondria, nucleus and secretory vesicles ([@B47]; [@B29]; [@B48]; [@B53]; [@B17]; [@B171]; [@B88], [@B90]; [@B49]; [@B157]; [@B173]; [@B130], [@B132]; [@B133]; [@B68]). Recent studies have shown the presence of CLIC1 in extracellular vesicles as well ([@B152]). Distribution of CLICs in these organelles contributes to their multifunctional role in modulating many key cellular functions. The physiological roles of CLICs and their pathophysiological effects are diverse and have been discussed in detail in recent reviews ([@B68], [@B67]).

Amongst the six mammalian paralogs, CLIC1, CLIC4, and CLIC5 are abundantly present in the heart ([@B130]; [@B133]). CLIC1 is present in the cardiac ER ([@B132]) whereas CLIC4 and CLIC5 localize to cardiac mitochondria. Apart from VDAC, CLIC4, and CLIC5 are the only other mitochondrial anion channels that have been identified at the molecular level. CLIC proteins auto-insert into membranes and can form functional redox-sensitive ion channels ([@B89], [@B90]; [@B158]). Even in the cardiac mitoplast, CLIC-like indanyloxyacetic acid-94 (IAA-94)-sensitive channel activity was observed ([@B104]), indicating their ability to form ion channels. CLIC proteins were first affinity-purified using its inhibitor IAA-94 ([@B83]). In addition, three sub conductance states were observed, which were attributed to the hetero-oligomerization of CLICs to allow them to function as ion channels ([@B167]). This further confirmed that CLICs form functional ion channels in mitochondria. CLICs are also involved in modulating mitochondrial ROS production. The absence of CLIC5 in cardiac mitochondria increased the rate of production and the total amount of mitochondrial ROS ([@B130]). IAA-94-sensitive chloride channels are also involved in modulating the calcium retention capacity (CRC) of the mitochondria ([@B131]). In the presence of IAA-94, the CRC was significantly reduced and caused early onset of mPTP opening ([@B131]) suggesting the possible involvement of CLICs in mPTP opening. These studies indicate that CLICs are important for regulating mitochondrial functions.

Chloride intracellular ion channel proteins are also present in immune cells and play a major role in immune activation and inflammasome mediated generation of pro-inflammatory responses ([Figure 1](#F1){ref-type="fig"}; [@B46]; [@B166]). Upon phagocytosis, CLIC1 has been shown to translocate to the phagosome membrane and promote phagosome acidifications ([@B76]). *Clic1^--/--^* macrophages showed impaired phagosome proteolytic capacity and ROS generation ([@B76]). In LPS-stimulated macrophages, it was observed that CLIC4 is an early response gene transcribed via the NF-κB and IRF3 pathways ([@B119]). In support of the transcriptional upregulation ([@B119]) of CLIC4, another study showed that CLIC4 expression was significantly increased in the brain, heart, liver, lung, kidney and spleen upon LPS injection in mice ([@B70]). Increased production of TNF, IL-6, IL-12, and CCL5 was observed in the stable CLIC4 overexpressed macrophage cell upon exposure to LPS. In addition, *clic4^--/--^* mice were resistant to LPS mediated death and had a reduced level of cytokines, indicating CLIC4 is important for mediating immune activation. In a recent report, both CLIC1 and CLIC4 were shown to activate NLRP3 inflammasome upon LPS stimulation ([@B46]). In the absence of CLIC1 or CLIC4 *via* siRNA mediated gene knockdown in bone marrow derived macrophages (BMDMs), it was observed that there was impaired transcription of IL-1β causing inactivation of the inflammasome complex ([@B46]).

Apart from mitochondrial mediated activation of inflammasome complexes, potassium (K^+^) efflux outside the cell membrane also triggers its activation ([@B108]). All of the three CLICs (CLIC1, CLIC4, and CLIC5) have been demonstrated to act downstream of the K^+^ efflux-mitochondrial ROS pathway to mediate NLRP3 inflammasome activation ([@B166]). In this study, it was shown that blocking CLICs with IAA-94 inhibited the activation of the NLRP3 inflammasome complex. Further, it was demonstrated that in the presence of an NLRP3 agonist, LPS, nigericin promoted potassium efflux, followed by mitochondrial damage and increased ROS production. Also, inhibition of mitochondrial ROS did not alter the nigericin induced potassium efflux suggesting that ROS production is downstream of K^+^ efflux. Interestingly, increased IL-1β secretion was inhibited in the presence of the mitochondrial ROS scavenger MnTBAP, suggesting that K^+^ efflux induces mitochondrial damage leading to ROS production in order to promote NLRP3 inflammasome activation. Furthermore, it was shown that nigericin induced an increase in enrichment of CLIC1, CLIC4, and CLIC5 in the plasma membrane of BMDMs. This in turn was inhibited in the presence of a mitochondrial ROS scavenger ([@B166]). These results indicate that K^+^ efflux leads to mitochondrial damage resulting in increased ROS production that then mediates a possible translocation of CLICs to the plasma membrane, causing chloride efflux ([@B166]). The CLICs translocation to the plasma membrane was shown to enhance the inflammasome assembly, caspase-1 activation and IL-1β release ([@B166]).

CLICs modulate mitochondrial functions such as mitochondrial ROS generation ([@B130]) and CRC ([@B131]) in cardiac mitochondria. Similar to cardiac mitochondria, CLICs might localize to mitochondria in macrophages. Thus, the role of mitochondrial CLICs in the regulation of inflammatory responses generated by macrophages *via* directly influencing mitochondrial function is still not clear and needs to be elucidated.

Mitochondrial Calcium Uniporter {#S3.SS4}
-------------------------------

Association of mitochondria with Ca^2+^ was indicated in 1953 ([@B160]). Later in the 1960s, it was demonstrated that rat kidney mitochondria can uptake Ca^2+^ which is dependent on the levels of ATP, Mg^2+^ and inorganic phosphate ([@B44]; [@B175]). After 50 years, the major source of Ca^2+^ entry to mitochondria *via* a mitochondrial calcium uniporter (MCU) was identified by two independent groups ([@B13]; [@B43]; [@B62]).

MCU is associated with many regulatory subunits including mitochondrial Ca^2+^ uptake (MICU1 and MICU2) and an essential MCU regulator (EMRE), which aids in its function of Ca^2+^ uptake ([@B128]; [@B96]; [@B40]; [@B129]; [@B147]; [@B79]; [@B126]; [@B185]; [@B105]). MICU1 is a Ca^2+^ sensing subunit which determines the activation of MCU ([@B40]). In its absence, mitochondria become overloaded with Ca^2+^, resulting in increased ROS and apoptosis ([@B96]). MICU1 and MICU2 work together to prevent Ca^2+^ uptake by the mitochondria when cytoplasmic Ca^2+^ is low ([@B79]). The other regulatory subunit, EMRE, bridges the interaction between MCU and MICUs, acting as a gatekeeper of the MCU by sensing Ca^2+^ in the matrix ([@B172]). In its absence, the MCU channel activity is lost. It is observed that MCU exhibits a 6--7 pS single channel activity and is sensitive to ruthenium red ([@B13]; [@B43]; [@B25]). Serine 259 residue in the pore forming domain was shown to be sensitive to ruthenium red ([@B25]).

Over the years, the importance of mitochondrial Ca^2+^ has been very well recognized in metabolism, ATP production and modulating cell death pathways ([@B62]). Further, it is understood that mitochondrial Ca^2+^ influences inflammatory responses (summarized in section "Mitochondrial Ca^2+^ and Inflammatory Response"), suggesting the potential role of mediators of Ca^2+^ homeostasis in mitochondria such as MCU in impacting inflammatory responses. Interestingly, the importance of MCU in inflammatory responses became evident in cystic fibrosis (CF) patients. CF patients exhibit a severe lung inflammatory response as characterized by the increased expression of pro-inflammatory cytokine IL-1β ([@B138]). This is mainly because CF airway epithelial cells show an increased pro-inflammatory response to the pathogen *Pseudomonas aeruginosa* ([@B138]). It was demonstrated that MCU expression rises upon the infection, and MCU dependent increased mitochondrial Ca^2+^ uptake activates the NLRP3 complex, causing mitochondrial dysfunction such as increased ROS generation and apoptosis. Thus, showing that MCU-dependent mitochondrial Ca^2+^ loading triggers an exacerbated inflammatory response in CF patients ([@B138]). Similarly, liver specific conditional knock out of its regulatory subunit, MICU1, increased the pro-inflammatory responses post partial hepatectomy ([@B4]). Higher levels of serum IL-6 and tissue specific increases in TNF-α and NF-κB activity was observed in the knock out mice post hepatectomy ([@B4]) eventually leading to the inhibition of liver tissue regeneration ([@B4]). MCU was also shown to regulate the type I interferon response, upon viral infection *via* induction of several interferon stimulated genes (ISGs) ([@B26]). It is established that viral infection always induces ER stress ([@B141]; [@B143]), which in turn plays a predominant role in determining the expression of proinflammatory cytokine ([@B73]; [@B71]). In this study, it was demonstrated that MCU: (1) interacts with the mitochondrial protein MAVS, and (2) this interaction is a pre-requisite for the activation of downstream events including phosphorylation of IRF3 and secretion of pro-inflammatory cytokine IFN-1β upon ER stress ([@B26]). Further knock down of either MCU or MAVS did not elicit expression of IFN-1β, suggesting the significance of the interaction of MCU and MAVS in MAVS-mediated immune activation ([@B26]). These results further suggest that similar to VDAC as described in section"Voltage dependent anion channels," MCU *via* its role in regulating Ca^2+^ exchange can possibly act as a link between the MAM and the mitochondria upon outer mitochondrial membrane permeabilization ([@B106]).

Other Channels and Transporters in Mitochondria {#S4}
===============================================

There are other channels, such as the calcium activated chloride channel (CLCC), volume regulated anion channel (VRAC), MITOK, small conductance calcium activated potassium (SK) channel and large conductance calcium and voltage activated potassium (BK) channels, that are either shown or predicted to be present in mitochondria ([@B123], [@B122]; [@B121]; [@B45]; [@B159]; [@B161]; [@B165]; [@B133]; [@B125]). Nevertheless, their presence and significance in modulating the immune response *via* regulating the mitochondrial structure-function of immune cells is still not known and needs further attention.

Concluding Remarks {#S5}
==================

Mitochondria are key organelles impacting cellular integrity by modulating several cell-death pathways. The functional role of mitochondria in generating inflammatory responses by regulating Ca^2+^ homeostasis, ROS generation, apoptosis and mitophagy/autophagy is well established ([Figure 1](#F1){ref-type="fig"}). In addition, oxidized mtDNA is also involved in activating the inflammasome complex. There are various inflammatory disorders as listed in [Table 1](#T1){ref-type="table"}, which are associated with defects in mitochondrial structure-function, thus indicating the importance of mitochondria in immune cells physiology. Many of these mitochondrial functions are also modulated by mitochondrial ion channels in physiological and severe pathophysiological conditions ([Figure 1](#F1){ref-type="fig"}). Although mitochondrial ion channels are very important in cellular processes, as well as in maintaining cellular integrity *via* modulating ionic homeostasis, limited information is available on their role in generating inflammatory responses. One of the reasons could be attributed to the lack of complete characterization and information on the molecular identity of mitochondrial ion channels ([@B133]). Some of the mitochondrial ion channels and transporters discussed above are well established in generating immune and inflammasome activation ([Figure 1](#F1){ref-type="fig"}), whereas the roles of other mitochondrial ion channels in regulating inflammatory processes still needs to be deciphered. Furthermore, knowledge with respect to their ionic conductance in mitochondria upon severe inflammatory conditions is necessary to recognize their significance in maintaining ionic homeostasis. Understanding the role and mechanisms of mitochondrial ion channels in elucidating inflammatory response would further provide new targets for therapeutics, which can be utilized as a treatment for many severe inflammatory disorders.
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AMP

:   adenosine mono phosphate

AMPK

:   AMP-activated protein kinase

ASC

:   apoptosis-associated spec-like protein containing a caspase recruitment domain

ATP

:   adenosine tri phosphate

BAK

:   BCL2 homologous antagonist/killer

BAT

:   brown adipose tissue

BAX

:   BCL2 associated X

BK

:   large conductance calcium and voltage activated potassium

BMDMs

:   bone marrow derived macrophages

CF

:   cystic fibrosis

cGAS

:   cyclic GMP AMP synthase

CHOK

:   choline kinase

CLCC

:   calcium activated chloride channel

CLICs

:   chloride intracellular ion channel proteins

CMPK

:   cytidine monophosphate kinase

CRAC

:   calcium release activated calcium channels

CRC

:   calcium retention capacity

DAMPS

:   damage associated molecular patterns

DeMP

:   degraded mitochondrial polypeptides

DNA

:   deoxyribonucleic acid

dNTP

:   deoxynucleotide tri phosphate

DRP

:   dynamin related peptide

EMRE

:   essential MCU regulator

ENaC

:   epithelial sodium channel

ER

:   endoplasmic reticulum

FPR

:   formyl peptide receptor

GMP

:   guanosine mono phosphate

GST

:   glutathione S transferase

HK

:   hexokinase

IAA-94

:   indanyloxyacetic acid-94

IL

:   interleukin

INF

:   interferon

IRF

:   interferon regulatory factor

ISG

:   interferon stimulated genes

LPS

:   lipopolysaccharide

MAM

:   mitochondria associated membranes

MAPK

:   mitogen activated protein kinase

MAVs

:   mitochondrial anti-viral signaling

MCU

:   mitochondrial calcium uniporter

MICU

:   mitochondrial calcium uptake

MOMP

:   mitochondrial outer membrane permeabilization

mPTP

:   mitochondrial permeability transition pore

NF

:   nuclear factor

NKCC

:   sodium potassium chloride-2 co transporter

NLR

:   NOD like receptors

NO

:   nitric oxide

NOD

:   nucleotide-binding oligomerization

OXPHOS

:   oxidative phosphorylation

PAMP

:   pathogen-associated molecular patterns

PRR

:   pattern recognition receptors

RA

:   rheumatoid arthritis

RNA

:   ribonucleic acid

RNS

:   reactive nitrogen species

ROS

:   reactive oxygen species

SIRS

:   systemic inflammatory response syndrome

SK

:   small conductance calcium activated potassium

STING

:   stimulator of interferon genes

TBK

:   TANK binding kinase

TCA

:   tricarboxylic acid

TNF

:   tumor necrosis factor

UCP

:   uncoupling protein

VDAC

:   voltage dependent anion channel

VRAC

:   Volume regulated anion channel.
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